The HSPB1 Knockout HAP1 Polyclonal Cells offer a CRISPR/Cas9-edited polyclonal knockout cell population targeting HSPB1 in the near-haploid HAP1 cell line. This pooled format comprises a heterogeneous mixture of cells carrying diverse loss-of-function mutations at the HSPB1 locus, providing robust gene disruption without requiring single-cell cloning. The polyclonal design minimizes clonal artifacts and is ideal for functional screens and population-level assays.
HAP1 is a near-haploid human cell line derived from KBM-7 chronic myeloid leukemia cells. Its haploid genome simplifies knockout studies by eliminating allelic compensation, enabling clear phenotypic analysis. HAP1 cells exhibit adherent growth, rapid proliferation, and compatibility with standard transfection and transduction methods, making them a valuable platform for reverse genetic approaches in cancer and signaling research.
HSPB1 encodes the small heat shock protein Hsp27, an ATP-independent chaperone crucial for stress resistance, actin cytoskeleton organization, and apoptosis inhibition. Under stress, p38 MAPK activates MAPKAPK2, which phosphorylates HSPB1, leading to actin filament stabilization and remodeling. HSPB1 also sequesters cytochrome c, preventing caspase-3 activation, and interacts with Bcl-2 and Bax to promote cell survival. Additionally, HSPB1 forms complexes with CRYAB and HSPB8, expanding its chaperone network.
In the HAP1 background, HSPB1 knockout provides a clean loss-of-function system to study p38 MAPK-mediated stress responses. The absence of a second allele ensures unambiguous phenotypes, making it suitable for investigating apoptosis and actin dynamics under oxidative or thermal stress. Given HAP1??s leukemic origin, this model is particularly relevant for studying cancer drug resistance and metastatic mechanisms where HSPB1 is often upregulated.
Key applications include immunoblotting for total and phosphorylated HSPB1, actin cytoskeleton staining, caspase activity assays, and cell viability tests following stress challenges. Migration and invasion assays can assess HSPB1??s role in motility, while pharmacological inhibition can dissect pathway dependencies. This polyclonal knockout population thus serves as a versatile tool for stress biology, oncology, and neuroprotection research. For further information, please contact Ascent Research.
